An announcement from Stimcell Energetics ( (STME) ) is now available.
On February 25, 2025, StimCell Energetics Inc. announced a partnership with ADM Tronics to redesign its eBalance® microcurrent device for home use. The collaboration aims to make the device smaller, more cost-effective, and equipped with advanced diagnostics, allowing consumers to monitor and enhance their well-being from home. This initiative is expected to make advanced microcurrent technology more accessible, potentially redefining consumer wellness by bridging the gap between clinical-grade solutions and home care.
More about Stimcell Energetics
StimCell Energetics Inc. is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications such as aging, insulin sensitivity, high blood pressure, neuropathy, and kidney function. The company’s main focus is on continued research and development of its eBalance® Technology and its eBalance® Home System.
YTD Price Performance: -3.67%
Average Trading Volume: 1,463
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $9.36M
For detailed information about STME stock, go to TipRanks’ Stock Analysis page.